Comparison of LVIS and Enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study
- PMID: 39242449
- DOI: 10.1007/s10143-024-02756-8
Comparison of LVIS and Enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study
Abstract
The role of a low-profile visualized intraluminal support stent (LVIS) and Enterprise in the treatment of unruptured intracranial aneurysms is well established. Although previous studies have investigated one single type of stent for the treatment of ruptured intracranial aneurysms (RIA), the safety and efficacy between the two types of stents has not been fully explored. Herein we conducted a study to compare the outcomes of the two stents for treatment of RIA. This is a prospective registry database of aneurysmal subarachnoid hemorrhage (aSAH) patients admitted to a single institution between 2018 and 2021. We collected patient baseline information, secondary complications, follow-up angiographic data, long-term prognostic outcomes, and conducted propensity score matching (PSM) analysis with 1:1 ratio and a multivariable logistic regression to compare the outcomes of the two types of stents. A total of 231 patients with RIAs were included in this study, with 108 treated using the LVIS device and 123 treated using the Enterprise device. Before PSM analysis, only the incidence of poor prognosis after 12 months was higher in the Enterprise group comparing to the LVIS group (20% vs. 10%, P = 0.049). After PSM analysis, there was a higher occurrence of delayed cerebral ischemia (DCI) in the Enterprise group compared to the LVIS group (odds ratio [OR] 3.95, 95% confidence interval [CI] [1.20-13.01], P = 0.024). However, no significant difference in prognosis was observed after PSM adjustment. Furthermore, subgroup analysis revealed that patients with female (P = 0.019), hypertension (P = 0.048), and anterior circulation aneurysms (P = 0.019) receiving the Enterprise device had a higher risk of DCI. The overall efficacy of LVIS and Enterprise in the treatment of RIA is comparable, while the incidence of DCI in the LVIS group is lower than that in the Enterprise group after PSM analysis. Registration number: NCT05738083 ( https://clinicaltrials.gov/ ).
Keywords: Enterprise; LVIS; Prognosis; Propensity score match; Ruptured intracranial aneurysms.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Claassen J, Park S (2022) Spontaneous subarachnoid haemorrhage. Lancet (London, England) 400(10355):846–862. https://doi.org/10.1016/s0140-6736(22)00938-2 - DOI - PubMed
-
- Hu P, Yan T, Li Y et al (2023) Effect of surgical clipping versus endovascular coiling on the incidence of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a multicenter observational cohort study with propensity score matching. World Neurosurg 172:e378–e388. https://doi.org/10.1016/j.wneu.2023.01.032 - DOI - PubMed
-
- Yi H, Shin D, Kim B, Lee D, Sung J (2023) Comparison of neuroform atlas stent-assisted coiling and coiling alone in ruptured intracranial aneurysms: a propensity score matching analysis. Neurosurgery 92(3):607–614. https://doi.org/10.1227/neu.0000000000002254 - DOI - PubMed
-
- Zhang L, Chen X, Dong L et al (2021) Clinical and angiographic outcomes after stent-assisted coiling of cerebral aneurysms with laser-cut and braided stents: a comparative analysis of the literatures. Front Neurol 12:666481. https://doi.org/10.3389/fneur.2021.666481 - DOI - PubMed - PMC
-
- Suzuki T, Takao H, Fujimura S et al (2017) Selection of helical braided flow diverter stents based on hemodynamic performance and mechanical properties. J NeuroIntervent Surg 9(10):999–1005. https://doi.org/10.1136/neurintsurg-2016-012561 - DOI
Publication types
MeSH terms
Associated data
Grants and funding
- 20224BAB216074/Natural Science Foundation of Jiangxi Province Youth Project
- 2022M721452/Postdoctoral Research Foundation of China
- 20212BBG71012/the Key Research and Development projects in Jiangxi
- 81960456 and 82172989/National Natural Science Foundation of China
- 2021ZDG02001/Jiangxi Branch of National Clinical Research Center for Geriatric Diseases
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
